| Product Code: ETC7552425 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India rare disease treatment market import shipment demonstrated a steady expansion with a CAGR of 3.0% from 2020-2024. Notably, there was a significant uptick in growth between 2023 and 2024, with a growth rate of 26.5%, indicating a strong positive momentum in the market during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Rare Disease Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Rare Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Rare Disease Treatment Market - Industry Life Cycle |
3.4 India Rare Disease Treatment Market - Porter's Five Forces |
3.5 India Rare Disease Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Rare Disease Treatment Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 India Rare Disease Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
4 India Rare Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of rare diseases in India |
4.2.2 Government initiatives and policies to support rare disease treatments |
4.2.3 Rise in research and development activities for rare disease treatments |
4.3 Market Restraints |
4.3.1 High treatment costs associated with rare diseases |
4.3.2 Limited availability of specialized healthcare facilities for rare disease treatments |
4.3.3 Lack of skilled healthcare professionals in the field of rare diseases |
5 India Rare Disease Treatment Market Trends |
6 India Rare Disease Treatment Market, By Types |
6.1 India Rare Disease Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Rare Disease Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 India Rare Disease Treatment Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 India Rare Disease Treatment Market Revenues & Volume, By Non-Biologics, 2021- 2031F |
6.2 India Rare Disease Treatment Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 India Rare Disease Treatment Market Revenues & Volume, By Genetic Diseases, 2021- 2031F |
6.2.3 India Rare Disease Treatment Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.2.4 India Rare Disease Treatment Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.5 India Rare Disease Treatment Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.6 India Rare Disease Treatment Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.7 India Rare Disease Treatment Market Revenues & Volume, By Other, 2021- 2031F |
6.3 India Rare Disease Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 India Rare Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Rare Disease Treatment Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 India Rare Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 India Rare Disease Treatment Market Import-Export Trade Statistics |
7.1 India Rare Disease Treatment Market Export to Major Countries |
7.2 India Rare Disease Treatment Market Imports from Major Countries |
8 India Rare Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted for rare disease treatments |
8.2 Percentage of rare disease patients receiving timely and appropriate treatment |
8.3 Adoption rate of innovative rare disease treatment technologies |
8.4 Number of collaborations between pharmaceutical companies and research institutions for rare disease treatments |
8.5 Patient satisfaction and outcome improvement measures in rare disease treatments |
9 India Rare Disease Treatment Market - Opportunity Assessment |
9.1 India Rare Disease Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Rare Disease Treatment Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 India Rare Disease Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
10 India Rare Disease Treatment Market - Competitive Landscape |
10.1 India Rare Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Rare Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here